BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7537533)

  • 1. Cloning the rat homolog of the CD28/CTLA-4-ligand B7-1: structural and functional analysis.
    Judge TA; Liu M; Christensen PJ; Fak JJ; Turka LA
    Int Immunol; 1995 Feb; 7(2):171-8. PubMed ID: 7537533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.
    Freeman GJ; Gray GS; Gimmi CD; Lombard DB; Zhou LJ; White M; Fingeroth JD; Gribben JG; Nadler LM
    J Exp Med; 1991 Sep; 174(3):625-31. PubMed ID: 1714935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.
    Steinberger P; Majdic O; Derdak SV; Pfistershammer K; Kirchberger S; Klauser C; Zlabinger G; Pickl WF; Stöckl J; Knapp W
    J Immunol; 2004 Feb; 172(4):2352-9. PubMed ID: 14764704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rat CD80 and CD86 by molecular cloning and mAb.
    Maeda K; Sato T; Azuma M; Yagita H; Okumura K
    Int Immunol; 1997 Jul; 9(7):993-1000. PubMed ID: 9237108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 is a second receptor for the B cell activation antigen B7.
    Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
    J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
    Freeman GJ; Borriello F; Hodes RJ; Reiser H; Gribben JG; Ng JW; Kim J; Goldberg JM; Hathcock K; Laszlo G
    J Exp Med; 1993 Dec; 178(6):2185-92. PubMed ID: 7504059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).
    Jellis CL; Wang SS; Rennert P; Borriello F; Sharpe AH; Green NR; Gray GS
    Immunogenetics; 1995; 42(2):85-9. PubMed ID: 7541777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine CD80: cloning, characterization, and evidence for its role in direct human T-cell activation.
    Tadaki DK; Williams A; Lee KP; Kirk AD; Harlan DM
    Xenotransplantation; 2003 May; 10(3):252-8. PubMed ID: 12694545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRC OX-2 defines a novel T cell costimulatory pathway.
    Borriello F; Lederer J; Scott S; Sharpe AH
    J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).
    McHugh RS; Ahmed SN; Wang YC; Sell KW; Selvaraj P
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8059-63. PubMed ID: 7544014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression.
    Gross JA; St John T; Allison JP
    J Immunol; 1990 Apr; 144(8):3201-10. PubMed ID: 2157764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
    Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
    J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.
    Vijayakrishnan L; Slavik JM; Illés Z; Greenwald RJ; Rainbow D; Greve B; Peterson LB; Hafler DA; Freeman GJ; Sharpe AH; Wicker LS; Kuchroo VK
    Immunity; 2004 May; 20(5):563-75. PubMed ID: 15142525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
    Freeman GJ; Freedman AS; Segil JM; Lee G; Whitman JF; Nadler LM
    J Immunol; 1989 Oct; 143(8):2714-22. PubMed ID: 2794510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.